Xenetic

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.

About XBIO

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.

CEO

Jeffrey F. Eisenberg

CEOJeffrey F. Eisenberg

Employees

Employees4

Headquarters

Framingham, Massachusetts

HeadquartersFramingham, Massachusetts

Founded

2011

Founded2011

Employees

Employees4

XBIO Key Statistics

Market cap

10.68M

Market cap10.68M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

108.12K

Average volume108.12K

High today

—

High today—

Low today

—

Low today—

Open price

$0.70

Open price$0.70

Volume

0.00

Volume0.00

52 Week high

$1.25

52 Week high$1.25

52 Week low

$0.2401

52 Week low$0.2401

XBIO Earnings

-$0.19

-$0.13

-$0.06

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 21, After Hours

ActualExpected Mar 21, After Hours

Xenetic

Why Robinhood?

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. Show more

XBIO Key Statistics

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.